OP0112 Abatacept Treatment Reduces Disease Activity in Early Primary Sjögren’s Syndrome (Phase II Open Label Asap Study)

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A89.2-A89 ◽  
Author(s):  
P. Meiners ◽  
A. Vissink ◽  
F. Kroese ◽  
F. Spijkervet ◽  
E. Haacke ◽  
...  
Keyword(s):  
Disease Activity ◽  
Phase Ii ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Primary Sjögren’S Syndrome ◽  
Primary Sjogren’S Syndrome ◽  
Open Label ◽  
Primary Sjögren's Syndrome ◽  
Early Primary ◽  
Sjögren‘S Syndrome

Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study

2005 ◽  
Vol 52 (9) ◽  
pp. 2740-2750 ◽  
Author(s):  
J. Pijpe ◽  
G. W. van Imhoff ◽  
F. K. L. Spijkervet ◽  
J. L. N. Roodenburg ◽  
G. J. Wolbink ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Primary Sjögren’S Syndrome ◽  
Primary Sjogren’S Syndrome ◽  
Open Label ◽  
Primary Sjögren's Syndrome ◽  
Open Label Phase ◽  
Sjögren‘S Syndrome
Sign in / Sign up

Export Citation Format

Share Document